NCT06671899

Brief Summary

The goal of this observational study is to determine if clinically constraint-induced movement therapy (CIMT), when applied in a routine clinical practice, can improve arm- and hand function after stroke. Additionally, the study seeks to identify which patients experienced the greatest improvements, and to examine factors that contribute to the long-term sustainability of the treatment. Stroke is one leading cause of disability, often resulting in difficulties using the arm and hand function on one side, making daily activities challenging. CIMT aims to enhance arm and hand function after stroke by incorporating intensive training and restraining the non-affected limb, thereby encouraging the use of the affected arm and hand. While numerous studies have demonstrated the effectiveness of CIMT, and it is recommended in national clinical guidelines, it is rarely implemented in clinical practice due to challenges in execution and sustainability. Moreover, it remains unclear which patients benefit the most from the treatment. At a rehabilitation clinic in Sweden, CIMT has been incorporated into routine care for 19 years, which is uncommon. Participants undergo CIMT as outpatients over a three-week period, with one patient being treated at a time. By retrospectively observe outcomes from this clinically implemented and sustained model of CIMT, the study aims to address the following questions:

  • Is CIMT, when conducted in a regular clinical setting, effective?
  • Are there relationships between patient characteristics and outcomes?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2000

Completed
18.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2018

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

October 15, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

18.4 years

First QC Date

October 15, 2024

Last Update Submit

November 13, 2024

Conditions

Keywords

stroke rehabilitationphysiotherapyoccupational therapyneurological rehabilitationupper extremityCIMTCI therapy

Outcome Measures

Primary Outcomes (1)

  • The Patient-Specific Functional Scale (PSFS)

    The Patient-Specific Functional Scale is a self-reporting tool meticulously designed to capture and document activity performance challenges identified as significant by the patient. The patients rate their performance on a numeric rating scale from 0 to 10 (0, unable to perform activity; 10, able to perform activity without difficulties or at pre-injury level). In this study, patients autonomously selected 1-5 activities aligned with their personal goals and rated their performance using the PSFS (a mean score for the self-identified activities was labelled PSFS-self). Additionally, patients assessed a single predetermined activity, namely eating with a knife and fork; which was included in the exercise programme for all patients on a daily basis (labelled PSFS-KF).

    From start to the end of treatment at 3 weeks, and at follow-up at 6 months.

Secondary Outcomes (5)

  • Motor Activity Log (MAL)

    From start to the end of treatment at 3 weeks, and at follow-up at 6 months.

  • The Box and Block Test (BBT)

    From start to the end of treatment at 3 weeks, and at follow-up at 6 months.

  • BL motor assessment

    From start to the end of treatment at 3 weeks, and at follow-up at 6 months.

  • Active range of motion (AROM)

    From start to the end of treatment at 3 weeks, and at follow-up at 6 months.

  • Modified Ashworth Scale (MAS)

    From start to the end of treatment at 3 weeks, and at follow-up at 6 months.

Study Arms (1)

CIMT in a clinical setting

Those who underwent modified constraint-induced movement therapy in a clinical setting in Sweden during the years 2000-2018.

Other: Constraint-induced movement therapy (CIMT)

Interventions

Clinically implemented modified CIMT. Including the three main components; intensive and repetitive task-oriented training of the affected limb, constraint of the non-affected limb and behavioural strategies known as the Transfer Package. In this model the training is supervised by therapist from several professions and some training sessions is performed in group settings with other inpatients and outpatients undergoing primary rehabilitation at the clinic.

CIMT in a clinical setting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients experiencing upper extremity impairments following neurological disorders who underwent a CIMT program at a multidisciplinary rehabilitation medicine clinic in Jönköping, Sweden during the years 2000 and 2018.

You may qualify if:

  • Post-acute injury (participants had completed primary rehabilitation and were living at home)
  • Reduced ability to use the hemi-paretic arm
  • Ability to actively extend the metacarpophalangeal and the interphalangeal joints 10°
  • Ability to actively extend the wrist 20°

You may not qualify if:

  • Unable to walk and balance safely without using the non-affected hand, with or without a mobility aid
  • Unable to understand the content of the training or lack of motivation
  • Serious cognitive deficit or instable medical condition believed to affect training participation
  • Pain in the affected arm believed to affect training intensity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation Medicine, Region Jönköping County

Jönköping, SE-551 85, Sweden

Location

MeSH Terms

Conditions

Stroke

Interventions

Constraint Induced Movement Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Kersti Samuelsson, Assoc.Prof.

    Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Registered Physiotherapist, Master of Science

Study Record Dates

First Submitted

October 15, 2024

First Posted

November 4, 2024

Study Start

August 14, 2000

Primary Completion

December 18, 2018

Study Completion

December 18, 2018

Last Updated

November 15, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations